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Objectives: We evaluated the role of three-dimensional power Doppler ultrasound (3D PD-US) to detect
endometrial lesions in women with postmenopausal endometrial bleeding.
Materials and methods: In this prospective observational study, from January 2009 to November 2012,
we recruited 225 postmenopausal women with postmenopausal uterine bleeding who met the study
criteria. Women who had hematologic disease, chronic medical diseases, or nonuterine pelvic diseases
were excluded. Prior to endometrial biopsy, the patients underwent a baseline transvaginal ultrasound
screening. The vascular indices and endometrial volumes were calculated with 3D PD-US and compared
with the endometrial histopathology.
Results: Among the endometrial histopathologic ﬁndings of 174 women, atrophic endometrium was the
most common ﬁnding (30.5%). Endometrial malignancy was conﬁrmed in 28 cases (16.1%), and endo-
metrial hyperplasia was diagnosed in 17 cases (9.8%). The prevalence of endometrial cancer was high in
patients who had endometrial thickness >9.5 mm (p < 0.001) and volume greater than 4.05 mL
(p < 0.001). For the endometrial carcinoma only, the cutoff values of vascular index, ﬂow index, and
vascular ﬂow index for predicting malignancy were 13.070, 12.610, and 3.764, respectively. For endo-
metrial hyperplasia, endometrial thickness and vascular ﬂow index were signiﬁcant ﬁndings.
Conclusion: Endometrial vasculature and volume can be obtained using 3D PD-US. The diagnostic use-
fulness of 3D PD-US for endometrial diseases is promising in women with postmenopausal endometrial
bleeding.
Copyright © 2015, Taiwan Association of Obstetrics & Gynecology. Published by Elsevier Taiwan LLC. All
rights reserved.Introduction
Postmenopausal bleeding is a common symptom in general
gynecological practice. The incidence of vaginal bleeding in post-
menopausal women is approximately 10% immediately after
menopause and 5% of all cases of menopause [1,2]. Various benign
genital causes of postmenopausal vaginal bleeding include atrophic
vaginitis, endometrial and cervical polyps, endometrial hyperpla-
sia, pyometra, and submucosal ﬁbroids. However, 10% of all women
presenting with postmenopausal bleeding may have endometrialand Gynecology, College of
, Busan 607-702, Republic of
bstetrics & Gynecology. Publishedmalignancy. Clinical investigations for those patients are mainly
directed to exclude malignant and premalignant lesions [3,4].
In the United States, endometrial cancer is the most common
type of gynecological cancer, and it is ranked fourth among all types
of cancer and seventh among all causes of death by cancer [5].
Cancers in the female reproductive organs account for 15.2% of all
types of cancer; however, endometrial cancer comprises only 1.9%
of all types of cancer, but the incidence is increasing with the
increased average lifespan and popularity of hormone replacement
therapy [6]. Endometrial cancer occurs in both the pre- and post-
menopausal periods, peaking when patients are in their 50s, and
postmenopausal uterine bleeding is the most common symptom of
endometrial cancer [3].
To our knowledge, endometrial sampling and histopathologic
review can provide a tentative diagnosis [7]. Transvaginal ultra-
sound as a noninvasive scan is the most commonly used ﬁrst-lineby Elsevier Taiwan LLC. All rights reserved.
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bleeding before endometrial sampling. Usually, a thick endome-
trium is indicative of further invasive evaluations such as endo-
metrial sampling and/or hysteroscopy [8,9]. However, conventional
two-dimensional (2D) ultrasound cannot assess all possible endo-
metrial pathologies. The recent developments with ultrasound
equipment enable new imaging techniques for volume scanning.
Unlike 2D ultrasound, three-dimensional (3D) ultrasound visual-
izes the whole endometrium on a coronal plane and can integrate
Doppler imaging to display the vascularity in the interested areas.
In this study, we applied 3D power Doppler ultrasound (3D PD-
US) in women with postmenopausal endometrial bleeding and
calculated various ultrasonographic vascular markers. Thus, we
aimed to determine the useful markers to predict endometrial
disease and evaluate the usefulness of 3D PD-US in post-
menopausal bleeding.
Materials and methods
Patients
We recruited all 225 women who visited the obstetrics and
gynecology departments of three university hospitals from January
2009 to November 2012 with a chief complaint of abnormal post-
menopausal endometrial bleeding. The study was conducted pro-
spectively in womenwho met the criteria. Menopause was deﬁned
as amenorrhea for at least 12 months. Patients with bleeding that
originated from the cervix, vagina, or vulva were not considered for
the observation. Among them, 174 patients were evaluated for
prospective correct diagnosis for bleeding after excluding patients
who had systemic and hematologic disorders, previous endome-
trial diagnosis, uterine bleeding due to disorders in the pelvis other
than in the uterus, or postmenopausal hormone therapy. All
women underwent physical examinations such as weight and body
mass index (BMI) evaluation, history, gynecologic evaluation, and
basic laboratory tests. Ethical approval for further evaluation and
use of data was granted by the Institutional Review Board of Kosin
Medical Center.
Ultrasound investigation
The patients underwent 2D transvaginal ultrasound scanning as
the initial investigation to evaluate the endometrium. Routine ul-
trasound was used for the diagnosis of the anatomical cause of
endometrial bleeding, such as uterine ﬁbroid. The endometrial
thickness was measured at its thickest point in an anteroposterior
dimension from one basal layer to other in a midsagittal plane.
Then, adjunctive 3D PD-US (Voluson E8; GE Healthcare, Zipf,
Austria) was carried out using uniform ultrasound modes, and the
obtained volume data were transferred to one investigator (A. Kim)
for volume and Doppler analysis. The settings were as follows:
frequency, 5 MHz; power Doppler gain, e5; dynamic range,
20e40 dB; edge,1; persistence, 2; color map, 5; motion ﬁlter, 1; and
pulse repetition frequency, 0.8 kHz. When a midsagittal view of the
uterus was obtained, the power Doppler mode was turned on. The
area of interest was the endometrium. The 3D mode was then
activated, and the area of interest was adjusted. Three-dimensional
volumetric data were obtained using automatic sweep, with the
angle being set to 120 to ensure that a complete endometrial
volume was included. The patients were asked to hold their breath
during volume acquisition. The multiplanar display was used to
ensure that the area of interest had been captured in its entirety.
After 3D volume storage, direct ultrasound examination was per-
formed to reduce examination time and patient discomfort. All 3D
volume data that were transferred were analyzed with a desktopcomputer equipped with Virtual Organ Computer-Aided Analysis
(VOCAL) software, which can calculate the targeted volume and
vasculatures. The results of the adjunctive 3D PD-US assessment
did not affect subsequent clinical management procedures because
the clinicians did not know the 3D PD-US results.
The manual mode of the VOCAL contour editor was used to
cover the 3D volume of the endometrium with 15 rotation steps.
The A-plane (sagittal view of the uterus) was rotated, and the
myometrialeendometrial junction from the fundus to the internal
cervical os was outlined in each rotation image (12 slices). Then, the
histogram demonstrated only the endometrium and showed the
endometrial volume with vascular indices (Figure 1). The three
automatically calculated vascular indices of the endometrium
included the vascularization index (VI), ﬂow index (FI), and
vascularization ﬂow index (VFI).
Endometrial sampling
Within 1 week after ultrasound examination, endometrial bi-
opsy was performed by cervical dilatation and curettage in
participating women after signed informed consent was obtained.
In the lithotomy position, the patient was prepared with povido-
neeiodine topical antiseptic solution and draped. After sedation,
the cervix was dilated with a Hegar dilater, and the endometrium
was curetted. The endometrial specimens were reviewed by pa-
thologists for ﬁnal diagnosis.
Statistical analysis
All results are presented as mean and standard deviation values
according to the distribution of data or number with %. The
KomologoroveSmirnov test was used to evaluate the normal dis-
tribution of the continuous data. Comparisons between two groups
were carried out with the Student t test. The receiver operating
characteristic curve was applied to calculate the predictive value of
the endometrial parameters for endometrial cancer or endometrial
hyperplasia. SPSS version 19.0 (SPSS Inc., Chicago, IL, USA) was used
for statistical calculations, and p < 0.05 was considered statistically
signiﬁcant.
Results
Among 225 patients who had undergone 2D and 3D PD-US, 174
completed the endometrial biopsy for diagnostic conﬁrmation
(Table 1). In total, 146 patients (83.9%) showed a benign endome-
trium, which could be of the following types: (1) proliferative
endometrium, (2) secretory endometrium, (3) glandular stromal
dissociation, (4) endometritis, (5) endometrial atrophy, (6) endo-
metrial polyp, and (7) endometrial hyperplasia. The most common
diagnosis among the benign diseases was endometrial atrophy (53
cases, 30.5%). However, endometrial malignancy was conﬁrmed in
28 cases (16.1%). Among these, 25 cases were diagnosed with
adenocarcinoma, while two cases were of squamous cell carcinoma
and one was of serous carcinoma.
Table 1 shows the comparison of clinical characteristics
including ultrasonographic data. In the malignant group, the mean
age was higher than that of the benign group (59.27 years and
61.04 years, respectively; p ¼ 0.023). Thus, there was a signiﬁcant
difference in the interval since menopause in the two groups
(mean, 9.24 years vs. 11.26 years; p ¼ 0.003). Patients with a ma-
lignant endometrium tended to have a higher BMI (mean, 27.32 kg/
m2 vs. 29.28 kg/m2; p ¼ 0.16).
In the endometrial evaluation with 2D ultrasound, the valuable
measurement was endometrial thickness. The endometrial thick-
ness was thicker in malignant cases than in benign cases (mean,
Figure 1. Histogram of endometrium and endometrial volume with vascular indices using power Doppler and VOCAL software.
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assessment with 3D PD-US can offer more variable parameters,
such as endometrial volume, VI, FI, and VFI. The endometrial vol-
ume was larger (mean, 2.90 mL vs. 5.56 mL; p < 0.001) and all
vascular indices were higher in patients with a malignant endo-
metrium (Table 1).
We analyzed the receiver operating characteristic curves of
endometrial thickness, volume, VI, FI, and VFI to assess their pre-
dictive value for malignancy (Fig. 2). The area under the curve was
statistically signiﬁcant in all parameters, including endometrialTable 1
Comparison of clinical characteristics between benign and malignant groups.
Characteristics Benign group
(n ¼ 146)
Malignant group
(n ¼ 28)
p
Age (y) 59.27 ± 5.25 61.04 ± 7.28 0.023
Body mass index (kg/m2) 27.32 ± 6.31 29.28 ± 8.16 0.016
Years since menopause 9.24 ± 2.14 11.26 ± 4.52 0.003
Endometrial thickness (mm) 8.70 ± 3.91 14.29 ± 3.60 <0.001
Endometrial volume (mL) 2.90 ± 1.26 5.56 ± 1.48 <0.001
Endometrial vascularization
index (%)
10.56 ± 6.59 17.80 ± 3.47 <0.001
Endometrial ﬂow index (0e100) 13.96 ± 7.24 17.45 ± 6.04 0.018
Endometrial vascularization
ﬂow index (0e100)
2.77 ± 2.23 9.17 ± 4.11 <0.001
Histological diagnosis
Proliferative Em 29 (16.67%)
Secretory Em 11 (6.32%)
Glandular stromal dissociation 10 (5.75%)
Endometritis 11 (6.32%)
Atrophy 53 (30.46%)
Polyp 15 (8.62%)
Hyperplasia 17 (9.78%)
Endometrial cancer 28 (16.09%)
Data are presented as mean ± standard deviation or number (%).
Comparisons between two groups were carried out using the Student t test.
EM ¼ endometrium.thickness and volume, for the prediction of endometrial cancer.
Table 2 shows that endometrial thickness, volume, VI, FI, and VFI
have predictive power for malignancy before the performance of
invasive endometrial biopsy. The best predictive cutoff value of
endometrial thickness for endometrial cancer was 9.5 mm. An
endometrial volume of >4.05mLwas also predictive of endometrial
malignancy. The vascular parameters were relative values, but, in
this mode setting, the cutoff values were 13.07 for VI, 12.61 for FI,
and 3.765 for VFI.
We also analyzed the predictive property or ultrasonographic
characteristics for endometrial hyperplasia (Figure 3 and Table 3).
The area under the curve for endometrial volume was not signiﬁ-
cant but reﬂected endometrial hyperplasia. Endometrial VI and VFI
were also not signiﬁcant; there was no signiﬁcant difference be-
tween other benign and hyperplastic endometria. However,
endometrial thickness and VFI showed a signiﬁcant difference be-
tween groups. The best predictive values were 7.5 mm for endo-
metrial volume and 2.275 for VFI.Discussion
Transvaginal ultrasound is currently used as the ﬁrst-step
technique in women with postmenopausal vaginal bleeding. It is
well known that ultrasound may reliably rule out endometrial
cancer when endometrial thickness is <5 mm [10]. Furthermore,
application of ultrasound towomenwith postmenopausal bleeding
is not invasive and is cost effective [11,12]. However, a thickened
endometrium alone is not indicative of endometrial pathology such
as malignancy. Other useful additive parameters or sonographic
ﬁndings should be used to predict endometrial malignancy.
Power Doppler angiography and 3D ultrasound have recently
been introduced in the gynecologic ﬁeld. These advanced tech-
niques overcome the limitations of color Doppler ultrasound and
conventional 2D ultrasound [13]. Three-dimensional ultrasound
can render the whole endometrium even in the coronal plane, and
Figure 2. Analysis of the ROC curves of endometrial thickness, volume, VI, FI, and VFI
to assess their predictive value for endometrial malignancy. FI ¼ ﬂow index;
ROC ¼ receiver operating characteristic; VFI ¼ vascular ﬂow index; VI ¼ vascular index.
Figure 3. Analysis of the ROC curves of endometrial thickness, volume, VI, FI, and VFI
to assess their predictive value for endometrial hyperplasia. FI ¼ ﬂow index;
ROC ¼ receiver operating characteristic; VFI ¼ vascular ﬂow index; VI ¼ vascular index.
Table 3
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built-in program. It has been accepted that the volume calculated
using VOCAL software may represent the true tissue volume [14].
The combination of 3D ultrasound and sensitive power Doppler
angiography allow for improved visualization of vessels, even for
arterioles or veins with slow velocity. The calculated vascular pa-
rameters, even if it they are relative, can provide comparable
indices. VI measures the number of color voxels in the volume,
which represents the vessels in the tissue and is expressed as a
percentage. FI is the mean color value in the color voxels, which
indicates the average intensity of blood ﬂow and is expressed as a
whole number from 0 to 100. VFI is the mean value of all the color
voxels in the volume, which represents both vascularization and
blood ﬂow, and is also expressed as a whole number from 0 to 100
[15]. These values are different from color Doppler vascular pa-
rameters, such as pulsatility index, resistance index, systolic/dia-
stolic ratio, or velocity. Vascular parameters for a speciﬁc diagnostic
approach can be calculated for various organs.
In the present study, we evaluated the role of 3D PD-US in
postmenopausal endometrial bleeding in distinguishing endome-
trial cancer from benign diseases. Postmenopausal endometrial
bleeding is the ﬁrst and most important symptom of endometrial
malignancy. We also found that the studied variables can predict
endometrial hyperplasia as compared with other benign diseases.Table 2
Receiver operating characteristic analysis of endometrial three-dimensional ultra-
sound and power Doppler angiography parameters for predicting malignancy.
Ultrasonographic data Benign group (n ¼ 146) versus malignant
group (n ¼ 28)
Area under
the curve
95% CI p Cutoff
value
Endometrial thickness (mm) 0.843 0.770e0.916 <0.001 9.50
Endometrial volume (mL) 0.920 0.873e0.966 <0.001 4.050
Vascularization index (%) 0.827 0.765e0.889 <0.001 13.070
Flow index (0e100) 0.653 0.550e0.756 0.010 12.610
Vascularization ﬂow
index (0e100)
0.933 0.894e0.972 <0.001 3.765
CI ¼ conﬁdence interval.We included all presenting women with postmenopausal
endometrial bleeding and with tentative diagnosis from endome-
trial curettage and biopsy. The women with a thin endometrium
(<5 mm) were not excluded, even though a thin endometrium is
not strongly associated with endometrial cancer. We wanted to
analyze the natural prevalence of endometrial cancer in post-
menopausal bleeding and to reduce the selection bias. Our preva-
lence of endometrial cancer was 16.1%, which was higher than that
of the reported results and therefore does not represent the general
population [3,4]. In addition to follow-up loss, exclusion of post-
menopausal hormone therapy can explain the higher prevalence.
Our results show that endometrial thickness volume may play
an important role in discriminating endometrial cancer from
benign diseases, which conﬁrm the ﬁndings of previous published
data regarding the correlation between endometrial cancer and
endometrial thickness or volume [11,13,16e18]. The positive cutoff
value was offered for the prediction of malignancy with an
endometrial thickness of 9.5 mm, not as the passive endometrial
thickness of 5 mm. This means that endometrial thickness of
>5 mm requires further evaluation with methods such as endo-
metrial biopsy, catheter sampling, whole curettage, orReceiver operating characteristic analysis of endometrial three-dimensional ultra-
sound and power Doppler angiography parameters for predicting endometrial
hyperplasia.
Ultrasonographic data Other benign group (n ¼ 129) versus endometrial
hyperplasia group (n ¼ 17)
Area under
the curve
95% CI p Cutoff value
Endometrial thickness
(mm)
0.724 0.614e0.834 0.003 7.50
Endometrial volume (mL) 0.609 0.480e0.738 0.144
Vascularization index (%) 0.636 0.544e0.728 0.069
Flow index (0e100) 0.504 0.397e0.612 0.954
Vascularization ﬂow
index (0e100)
0.852 0.753e0.951 <0.001 2.275
CI ¼ conﬁdence interval.
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9.5 mm is worthy of attention and is evaluated with malignancy in
mind. With regard to endometrial volume, a larger volume must
be associated with a thick endometrium and, of course, can be
related to endometrial cancer. We assessed the cutoff values of
endometrial volume for the prediction of cancer as 4.05 mL, which
is not small compared with that of the reproductive endometrium
[19]. The inter- and intraobserver variations were small in the
volume calculation in the 3D VOCAL program, and thus, increased
endometrial volume seems to be indicative of endometrial cancer
[20].
Endometrial vascular assessment for predicting malignancy has
been studied in several reports [13,21e24], all of which concluded
that 3D PD-US analysis of vascularization in endometrial cancer
correlates with the diagnosis in women with or without endome-
trial bleeding. In some studies, the subendometrial vasculature
calculated by 3D PD-US can also be valuable for the prediction of
myometrial invasion of endometrial carcinoma [22]. In the present
study, previous published datawere conﬁrmedwith regard to VI, FI,
and VFI. Endometrial cancer tends to have higher vasculature in the
endometrium. This study differed from previous studies due to the
large number of participants with bleeding, more cases with a
diagnosis of cancer, and smaller prospective collection bias of this
study. Thus, we can conclude that endometrial cancer increases the
vasculature of the endometrium, which can be applied for the
prediction of malignancy. The cutoff value in the study cannot be
applied to all patients with postmenopausal endometrial bleeding
because the parameters vary according to the setting mode and
ultrasound model.
The group with endometrial cancer showed a higher age dis-
tribution, interval from menopause, and BMI, a well-known risk
factor for endometrial malignancies [16]. However, we focused on
the endometrial characteristics for the prediction of malignancy, so
these clinical variables were not considered for correlation with
endometrial ultrasonographic characteristics.
We focused on the relationship of endometrial characteristics
evaluated by ultrasound and endometrial hyperplasia, which has
been studied in a previous report [21]. The measurements for
endometrial thickness, volume, VI, and FI were signiﬁcantly higher
in both the hyperplasia and the carcinoma groups [21]. Discrimi-
nation of hyperplasiawas the only meaningful analysis of the study,
and the signiﬁcant variables were endometrial volume and VFI.
This ﬁnding can be explained by the fact that postmenopausal
women have the limitation of volume increase for a decreased
uterus and thus a limitation in measuring vascularity. However,
typical endometrial thickening >7.5 mm is meaningful for the
prediction of endometrial hyperplasia. The cutoff of VFI for endo-
metrial hyperplasia is smaller than that of endometrial cancer, but
greater endometrial vasculature can be associated with endome-
trial hyperplasia.
We prospectively analyzed, beyond the previous studies, with a
larger group of women with postmenopausal endometrial
bleeding. The various analyses were not permitted for the limita-
tion of the recruitment of patients, and a randomized controlled
trial is needed to clarify the results of this study. Nevertheless, the
present study demonstrated the predictive values for endometrial
cancer and hyperplasia.
Based on the ﬁndings and assessment of the present study,
although endometrial thickness appears to be the simplest with 2D
ultrasound, endometrial thickness and VFI were more accurate in
diagnosing endometrial hyperplasia according to the receiver
operating characteristic curves. Furthermore, all parameters of the
endometrium, such as thickness, volume, VI, FI, and VFI, have
higher scores for endometrial malignancy in women with post-
menopausal endometrial bleeding. Thus, physicians must focus onendometrial thickness >9.5 mm for malignancy and >7.5 mm for
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